Getinge AB Class B
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|fJ | LOCK|FwS | LOCK|JWpp>G |
Getinge's Fundamentals Intact as Demand for High-Margin Products Remains Strong
Business Strategy and Outlook
Getinge is a Swedish medical technology firm specializing in operating room equipment, critical-care technologies, and sterilization solutions for hospitals and biopharmaceutical manufacturers. Over the past decade, the company has faced significant regulatory scrutiny, including a 2015 US consent decree, product liability settlements related to surgical mesh, multiple product recalls, and recent US Food and Drug Administration letters regarding its Cardiosave and Cardiohelp cardiovascular devices. These challenges have required increased investment in quality systems and product remediation, which has persistently pressured margins. With the recent FDA submission for Cardiosave, we hope Getinge can soon leave this chapter behind.
